Move easy
Osteoarthritis (OA) the second most common rheumatologic problem and it is the most frequent joint disease with a prevalence of 22% to 39% in India. The physical disability arising from pain and loss of functional capacity reduces quality of life…
Peripheral neuropathy is a nerve-damage condition affecting sensory, motor, or autonomic pathways. It impacts approximately 2.4% of the global population, with prevalence increasing to nearly 7% in adults over 45. Common symptoms include pain, tingling, numbness, muscle weakness, and reduced reflexes.
Osteoarthritis (OA) the second most common rheumatological problem and it is the most frequent joint disease with a prevalence of 22% to 39% in India. The physical disability arising from pain and loss of functional capacity reduces quality of life and increases the risk of further morbidity.
Medical management of OA includes weight reduction, physiotherapy, and pharmacotherapy. These have only modest benefits and aim at reducing pain, improving joint mobility and quality of life. Surgical intervention in the form of replacement surgeries are usually the last resort.
The first line treatment in early stages includes weight reduction, use of ambulatory aids, intra-articular steroid injections and non-steroidal anti-inflammatory drugs (NSAIDs). Abuse of NSAIDs is common and can cause gastrointestinal toxicity in 50% of the users, while 5.4% develop a more serious event like cardiovascular diseases requiring hospitalization.
Hence there is a need for a natural solution for management of OA which is effective and safe.
BLM OsteoVida contains avocado and soybean unsaponifiables (ASU), made from fruits and seeds of avocado and soybean oil. Characterized by its potent anti-inflammatory effects, this ASU mixture is recommended to act as an adjuvant treatment for osteoarthritic pain and slow-acting symptomatic treatment of hip and knee osteoarthritis. AVOVIDA is a branded proprietary ASU ingredient which has been clinically tried in Europe and USA.
PROTECT, BUILD & REPAIR
Osteoarthritis
Peripheral neuropathy is a nerve-damage condition affecting sensory, motor, or autonomic pathways. It impacts approximately 2.4% of the global population, with prevalence increasing to nearly 7% in adults over 45. Common symptoms include pain, tingling, numbness, muscle weakness, and reduced reflexes.
BLM NeuroVive provides clinically supported neuro-regenerative support for peripheral neuropathy. It contains Uridine Monophosphate (UMP), Cytidine Monophosphate (CMP), Vitamin B1 and Vitamin B12. Together, these help promote nerve repair, remyelination, and relief from neuropathic discomfort.
Comprehensive Nucleotide Therapy for Peripheral Neuropathy & Nerve Regeneration
Peripheral Neuropathy
